Epclusa Prices, Coupons and Patient Assistance Programs
Epclusa (sofosbuvir/velpatasvir) is a member of the antiviral combinations drug class and is commonly used for Hepatitis C.
Epclusa Prices
This Epclusa price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Epclusa oral tablet (400 mg-100 mg) is around $26,025 for a supply of 28 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Epclusa is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Epclusa availability.
Oral Tablet
| Quantity | Per unit | Price |
|---|---|---|
| 28 | $929.45 | $26,024.54 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
Print NowThe free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Epclusa Coupons and Rebates
Epclusa offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Epclusa Co-Pay Coupon: Eligible patients may pay no more than $5 with a maximum savings of 25% per 12-week regimen; for additional information contact then program at 855-769-7284.
| Applies to: | Epclusa |
| Number of uses: | Per prescription until program expires |
Patient Assistance Programs for Epclusa
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:
- *See Additional Information section below
- Between 400-500% of FPL
- Medically appropriate condition/diagnosis
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Epclusa (sofosbuvir-velpatasvir)
Provider: Good Days Program
Elligibility requirements:
- Not specified
- Not disclosed
- Not specified
- US residency requirements are not specified.
- Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
Applicable drugs:
- Epclusa (sofosbuvir-velpatasvir)
Provider: Support Path Patient Assistance Program
Elligibility requirements:
- Must be uninsured and be ineligible for federal or state programs; or have a plan design limitation
- At or below 500% of FPL* (see below)
- *See Additional Information section below
- The patient must also be permanently residing in the US or US territories.
- *500% FPL or less than $100k for the household This program also provides copay assistance. Patient must be diagnosed with Chronic Hepatitis C.
Applicable drugs:
- Epclusa (sofosbuvir-velpatasvir) Tablet
More about Epclusa (sofosbuvir / velpatasvir)
- Epclusa Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 106 Reviews – Add your own review/rating
- Drug class: antiviral combinations
